In recent years, a number of factors essential
for telomerase regulation and telomere maintenance have been identified.
Researchers at the Spanish National Cancer Research Centre (CNIO) published proof - of - principle results showing a role
for telomerase reverse transcriptase (TERT)...
Blasco PM, María A. Telomeric and extra-telomeric roles
for telomerase and the telomere - binding proteins.
Her lab also discovered a hidden regulatory landscape on the surfaces of cellular proteins, which act as traffic cops
for telomerase.
Methods: Human corneas with attached scleral rims were obtained from eye banks and were assayed
for telomerase activity and BrdU (bromodeoxyridine) incorporation to determine, respectively, the presence of a stem - like cell marker and replicative activity.
Donor tissue alone (lane 1) is negative
for telomerase.
Those assays were negative
for telomerase activity (data not shown).
In this study, the reaction
for telomerase in the peripheral corneal endothelium was manifest (Figure 2).
Within this portion they identified the TFLY, a conserved element that they showed is involved in binding the RNA component of telomerase and this interaction is important
for telomerase protein - RNA assembly and activity.
This widespread lack of the need
for telomerase is used by evolution as a key component of our defense against cancer, because having a limit to the size and renewal of telomeres prevents our cells from replicating themselves indefinitely — the crucial hallmark of cancer.
If it weren't
for telomerase, this gradual shortening would eventually lead to the complete loss of the telomeres in cells that replicate frequently during a life span, and thus the gradual erosion of the genes themselves.
In August, 1997, Nobelist Thomas Cech of the University of Colorado at Boulder and colleagues at Geron isolated the human gene
for telomerase reverse transcriptase (hTRT)-- an enzyme that reknits loosening telomeres and extends a cell's life.
The grueling 18 months unearthed a gold mine: Lundblad's team found three genes that are crucial
for telomerase function, results that generated a flurry of groundbreaking papers from the members of her group in 1996 and 1997.
Not exact matches
The underlying reason is that Geron and partner Johnson & Johnson (NYSE: JNJ) are developing a first - in - class
telomerase inhibitor called imetelstat
for the rare blood disorders myelodysplastic syndromes (MDS) and myelofibrosis (MF).
Variants in the gene called
Telomerase Reverse Transcriptase (TERT) on chromosome 5 that were associated with older IEAA were also associated with longer telomeres indicating a critical role
for TERT in regulating the epigenetic clock, in addition to its established role of compensating
for cell replication - dependent telomere shortening.
Voice: The 2009 Nobel Prize in Physiology or Medicine goes to Harvard's Jack Szostak, Johns Hopkins's Carol Greider and Elizabeth Blackburn at U.C. San Francisco
for their work on how chromosomes are protected by telomeres and the enzyme
telomerase.
For instance, one small study found that people who ate healthier diets, did yoga or meditation, and exercised daily increased the activity of
telomerase, which could lead to longer telomeres.
For now, the only diseases clearly caused by shortened telomeres or dysfunctional
telomerase are rare premature aging disorders like dyskeratosis congenita.
Telomerase adds back the lost DNA and keeps cancer cells,
for example, forever young.
Several biotech companies — most prominently Geron, which first made a name
for itself in telomere research — are working to develop anticancer drugs that would work by deactivating
telomerase.
New experiments by UC Berkeley and UCSF researchers suggest that immortalization of skin cells, which is essential to turning them cancerous, is a two - step process: a mutation in nevus cells slightly raises levels of
telomerase, which keep the cells alive long enough
for a second change, still unknown, that up - regulates
telomerase to make the cells immortal and malignant.
«Our findings have implications
for how to think about the earliest processes that drive cancer and
telomerase as a therapeutic target.
Some would simply crank their
telomerase activity up even further; some would enhance the activity of drug - metabolizing enzymes that degrade the inhibitor; still others would change their cell surface proteins in ways that would make it harder
for the drug to penetrate into the cell.
The TERT promoter mutation does not generate enough
telomerase to immortalize the pre-cancerous cells, but does delay normal cellular aging, Hockemeyer said, allowing more time
for additional changes that turns
telomerase up.
As with all of our other genes, the DNA that encodes the
telomerase enzyme is present in all of our cells — but because it's needed only after quite a few cell divisions have occurred, it's not needed in most cells
for most or all of the time, so it's turned off.
To insiders,
telomerase was a much better prospect
for drug development than the Werner protein.
However, the researchers believe that these results are proof of concept that gene therapy is a valid strategy against aplastic anemia; this therapy could also be applied to other genes — besides from
telomerase — if a causal role
for those other forms of the disease was discovered.
«This TFLY motif comprises a significant part of the binding pocket that enables the enzyme to grapple the RNA template and guide it to the active site of the enzyme
for catalysis,» Skordalakes said, «but it also facilitates the stable association of the protein with its RNA component thus forming a fully functional
telomerase enzyme.»
In their research project in 2012, the researchers substantially delayed the aging of mice by enabling their cells to produce
telomerase once again
for a period of time.
This model structure of the catalytic portion of
telomerase shows how the TFLY motif (green) is positioned at the entry of the pocket that guides the RNA template in the interior cavity of the
telomerase ring and were the active site of the enzyme if located
for catalysis.
The treatment is based on making bone marrow cells express the
telomerase enzyme, which is responsible
for repairing telomeres.
While increased
telomerase activity could bring youth to aging cells and cure premature aging - like diseases, too much of a good thing can be damaging
for the individual.
When
telomerase restarts DNA synthesis
for the next DNA repeat, this pause signal is still active and limits DNA synthesis.
Small molecule drugs can be screened or designed to increase
telomerase activity exclusively within stem cells
for disease treatment as well as anti-aging therapies without increasing the risk of cancer.
«People have been targeting
telomerase as a potential cancer therapy
for a long time,» he says, noting that anti-
telomerase drugs are in phase II clinical trials against several cancers.
Augmenting and regulating
telomerase function will have to be performed with precision, walking a narrow line between cell rejuvenation and a heightened risk
for cancer development.
In this webinar, our experts will describe the advances in telomere research as it applies to human health and how deeper characterization of the
telomerase maintenance process can uncover targets
for therapies.
When it filed
for a patent on the gene, it didn't list the academic collaborators as co-inventors, although Greider maintains that her lab contributed biochemical protocols
for purifying
telomerase that were crucial to Geron's discovery.
Greider and Ariel Avilion, a grad student working in her lab toward a Ph.D. from the State University of New York, Stony Brook, were attempting to find and isolate the gene
for the RNA portion — dubbed hTR — of human
telomerase.
The studies on autophagy by Yoshinori Ohsumi, which earned him the Nobel Prize in Medicine in 2016, and the discovery of cell cycle regulatory genes
for which Leland Hartwell, Timothy Hunt and Paul Nurse received the same award in 2001, including the research of Elizabeth Blackburn, Carol Greider and Jack Szostak on telomeres,
telomerase and its protective effect on the chromosomes, were all made possible thanks to yeast.
Telomerase is an enzyme responsible
for the production of telomeres, which play an important role in the regulation of normal cell division.
They have become a valuable resource
for biologists, enabling momentous scientific breakthroughs including the development of the polio vaccine the Nobel Prize winning studies defining the role of
telomerase in aging, and research on the causative role of human papillomavirus (HPV) in some types of cervical cancer.
Arsenic, the researchers found, stops a gene
for an important part of the
telomerase enzyme, known as the reverse transcriptase subunit, from being translated.
Scientists say that the findings are exciting because, though disrupting
telomerase has looked like a good strategy
for treating cancer, it's been difficult to pinpoint compounds that do so.
As a safeguard, in cells such as egg, sperm, and stem cells, an enzyme called
telomerase is responsible
for preventing this wear and tear by maintaining telomere length.
The 2009 Nobel Prize in physiology or medicine goes to Harvard's Jack Szostak, Johns Hopkins's Carol Greider and Elizabeth Blackburn at U.C. San Francisco,
for their work on telomeres and
telomerase.
An inherently high stalling frequency of the S. cerevisiae
telomerase may account
for its in vitro properties and
for the irregular telomeric sequences of this yeast.
Related sites Richard Cawthon's Web site Basic introduction to telomeres and
telomerase American Federation
for Aging Research
Telomerase has been hailed as a potential elixir
for eternal youth.
The
telomerase ribonucleoprotein has a phylogenetically divergent RNA subunit, which contains a short template
for telomeric DNA synthesis.